| Patents for A61P 33 - Antiparasitic agents (21,787) |
|---|
| 06/02/2000 | WO2000031097A1 13-membered azalides and their use as antibiotic agents |
| 06/02/2000 | WO2000031085A1 Organophosphorous compounds and the use thereof |
| 06/02/2000 | WO2000031065A1 Compounds having cytokine inhibitory activity |
| 06/02/2000 | WO2000031033A1 Piperidine ccr-3 receptor antagonists |
| 06/02/2000 | WO2000030653A2 Use of phosphonoformic acid derivatives for treating infections |
| 06/02/2000 | WO2000030625A2 Use of phosphonoformic acid derivatives for treating infections |
| 06/02/2000 | WO2000030449A1 Antiparasitic formulations |
| 06/02/2000 | CA2352549A1 Use of phosphonoformic acid derivatives for treating infections |
| 06/02/2000 | CA2352511A1 Use of phosphonoformic acid derivatives for treating infections |
| 06/02/2000 | CA2352317A1 Amino alkylphosphonic acid derivatives and their use in treating infections |
| 06/02/2000 | CA2351631A1 Piperidine quaternary salts-ccr-3 receptor antagonists |
| 06/02/2000 | CA2351361A1 Gtpase associated proteins |
| 06/02/2000 | CA2350969A1 Compounds having cytokine inhibitory activity |
| 05/31/2000 | EP1004590A2 Glucidic esters of branched carboxylic acids capable of inducing erythroid cellular differentiation |
| 05/31/2000 | EP1004589A1 Phosphoryl hydrazine insecticides . |
| 05/31/2000 | EP1003771A1 Linear peptides derived from antibiotic peptides, preparation and use for vectoring active substances |
| 05/31/2000 | EP1003770A1 Secreted proteins and polynucleotides encoding them |
| 05/31/2000 | EP1003764A1 Improved process for antiparasitic agent |
| 05/31/2000 | EP1003763A1 83 human secreted proteins |
| 05/31/2000 | DE19854403A1 Phosphororganische Verbindungen und ihre Verwendung Organophosphorus compounds and their use |
| 05/31/2000 | DE19854402A1 Verwendung von Phosphonameisensäurederivaten zur therapeutischen und prophylaktischen Behandlung von Infektionen Using Phosphonameisensäurederivaten for the therapeutic and prophylactic treatment of infections |
| 05/31/2000 | CN1255060A Pharmaceutical compositions of tizoxanide and nitazoxanide |
| 05/31/2000 | CN1254596A Process for preparing composition to kill internal parasites |
| 05/30/2000 | US6068843 An amount of a 56 kda polypeptide encoded by a 2.3 kb hindiii partial digest restriction fragment of serpulina hyodysenteriae b204 effective to produce a protective immune respone against serpulina hyodysenterie infection in swine |
| 05/25/2000 | WO2000029435A1 12 human secreted proteins |
| 05/25/2000 | WO2000029378A2 Acyclic and cyclic guanidine- and acetamidine derivatives, their preparation and their use as pesticides, esp. as parasiticides |
| 05/25/2000 | WO2000017233A3 Genes of the 1-desoxy-d-xylulose biosynthetic pathway |
| 05/25/2000 | WO2000010595A3 Medicaments for manipulating t-cell immune response |
| 05/25/2000 | DE19955793A1 CCR-3-Rezeptor-Antagonisten CCR-3 receptor antagonists |
| 05/25/2000 | CA2350742A1 Acyclic and cyclic guanidine- and acetamidine derivatives, their preparation and their use as pesticides, esp. as parasiticides |
| 05/25/2000 | CA2348824A1 12 human secreted proteins |
| 05/24/2000 | EP1002108A2 Use of mhc class ii ligands as adjuvant for vaccination and of lag-3 in cancer treatment |
| 05/24/2000 | EP1001962A1 Production of avermectin compounds |
| 05/24/2000 | EP1001806A1 Cellular vesicle called ''exosome'', preparation and use thereof in immune stimulation |
| 05/23/2000 | US6066722 Nucleoside analogues used as antiprotozoal agents especially against plasmodium |
| 05/23/2000 | US6066503 Recombinant DNA molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections |
| 05/23/2000 | US6066319 Administering membrane attack complex (mac) transmembrane channel forming agent which is an antibody simultaneously therewith an effective amount of a therapeutic or diagnostic agent |
| 05/18/2000 | WO2000027369A1 Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use |
| 05/18/2000 | WO2000027359A1 An inhalation system |
| 05/18/2000 | WO1999063824B1 Control of parasitic infestations in farmed and wild fish |
| 05/18/2000 | DE19852508A1 Use of fat-soluble substance obtained from avocado oil as an antiphlogistic, antirheumatic, antimycotic or antiscabiotic agent, or as a toothpaste, lipstick, leather treatment agent or in bandages |
| 05/18/2000 | CA2351063A1 A system for administering a bioactive agent by inhalation comprising a lipid mixture comprising phosphatidylcholine |
| 05/17/2000 | EP0999852A1 Oil in water vaccine compositions |
| 05/17/2000 | EP0999842A1 Novel substituted imidazole compounds |
| 05/17/2000 | CN1253555A Novel 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same |
| 05/17/2000 | CN1253176A Composition and method for protecting animals from diseases related with slow action virus |
| 05/16/2000 | US6063771 Formulations for controlling human lice |
| 05/16/2000 | US6063610 Flea hydrolase enzyme; for development of antibodies to prevent parasitic infection of plant and animals |
| 05/11/2000 | WO2000026385A1 Nucleic acid constructs for genetic immunization |
| 05/11/2000 | WO2000026224A2 Novel macrolide antibiotics |
| 05/11/2000 | WO2000026208A1 N-oxides of heterocyclic compounds with tnf and pde-iv inhibiting activity |
| 05/11/2000 | WO2000025812A2 Method for preparing solid phase conjugate vaccines |
| 05/11/2000 | WO2000025810A2 Immunomodulatory factors for immunosuppressant and antiallergic treatment |
| 05/11/2000 | WO2000025791A1 Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines |
| 05/11/2000 | WO2000009150A3 Cytokine and cytokine receptor, agonist, antagonist and/or antibody combination for therapeutic use |
| 05/11/2000 | CA2349505A1 Nucleic acid constructs for genetic immunization |
| 05/11/2000 | CA2348063A1 Method for preparing solid phase conjugate vaccines |
| 05/11/2000 | CA2312430A1 N-oxides of heterocyclic compounds with tnf and pde-iv inhibiting activity |
| 05/10/2000 | CN1252808A Antipathogenic synthetic piptides and compositions comprising them |
| 05/10/2000 | CN1052236C Process for prepn. of ivermectin |
| 05/10/2000 | CN1052227C Oxazolidone used as adhesive receptor antagenists, its preparing method and medicinal composition containing them |
| 05/09/2000 | US6060061 Method for preventing or treating disorders involving an inflammatory process |
| 05/09/2000 | CA2181168C Antiparasitic pyrrolobenzoxazine compounds |
| 05/09/2000 | CA2065285C Antimalarial compositions |
| 05/04/2000 | WO2000024411A2 Plant-derived anti-parasitic and antifungal compounds and methods of extracting the compounds |
| 05/04/2000 | WO2000006730A3 Human cytoskeletal proteins |
| 05/03/2000 | EP0997529A2 Feline immunodeficiency virus strain FIV-141 and uses thereof |
| 05/03/2000 | EP0996710A1 Component of bromelain |
| 05/03/2000 | EP0996614A1 Acrylonitrile compounds, process for their production and pesticides containing them |
| 05/03/2000 | EP0996446A1 Novel substituted imidazole compounds |
| 05/03/2000 | EP0996439A1 $g(b)-ALKOXYACRYLATES AGAINST MALARIA |
| 05/03/2000 | EP0785924B1 Bis-2-aminopyridines, preparation method therefor and use thereof for controlling parasitic infections |
| 05/03/2000 | CN1252101A Component of bromelain |
| 05/03/2000 | CN1252096A Component of bromelain |
| 05/02/2000 | US6057369 Use in the treatment of disease states associated with proteins that mediate cellular activity which are capable of being modulated by inhibiting a matrix metalloproteinase (mmp), tumor necrosis factor (tnf) or cyclic amp |
| 05/02/2000 | US6057351 Compounds of the 3-aryl 2,4 dioxo oxazolidine family and use thereof in cosmetic and pharmaceuticals |
| 04/27/2000 | WO2000023592A2 Minimal promoters and uses thereof |
| 04/27/2000 | WO2000023572A1 Tnfr related gene 12 |
| 04/27/2000 | WO2000023117A1 Photosensitizer conjugates for targeting intracellular pathogens |
| 04/27/2000 | WO2000023105A2 Adjuvant systems and vaccines |
| 04/27/2000 | WO1999057271A9 Feline cd80, feline cd86, feline cd28, and feline ctla-4 nucleic acid and polypeptides |
| 04/27/2000 | CA2773698A1 Adjuvant systems comprising an immunostimulant adsorbed to a metallic salt particle and vaccines thereof |
| 04/27/2000 | CA2347369A1 Minimal promoters and uses thereof |
| 04/27/2000 | CA2347099A1 Adjuvant systems comprising an immunostimulant adsorbed to a metallic salt particle and vaccines thereof |
| 04/27/2000 | CA2347080A1 Tnfr related gene 12 |
| 04/27/2000 | CA2347045A1 Photosensitizer conjugates for targeting intracellular pathogens |
| 04/26/2000 | EP0995799A2 Coccidiosis vaccines |
| 04/26/2000 | EP0995120A1 Protein elongation factor 2 as a target for antifungal and antiparasitic agents |
| 04/26/2000 | EP0656945B1 Stress protein epitopes |
| 04/26/2000 | CN1251529A Use of bacterial cell wall extracts for treating, preventing or removing protozoa or parasitism diseases |
| 04/25/2000 | US6054135 Compounds and methods for the detection and prevention of T. cruzi infection |
| 04/20/2000 | WO2000022143A2 Protein kinase homologs |
| 04/20/2000 | WO2000021979A2 Cyclic tetrapeptide and their use as histone deacetylase inhibitor |
| 04/20/2000 | WO2000021946A1 3-phenyl-pyrones |
| 04/20/2000 | WO2000021371A1 Oral combination of lufenuron and nitenpyram against fleas |
| 04/20/2000 | DE19846517A1 New 3-phenyl-4-hydroxy-2-pyrone derivatives useful as pesticides, herbicides and fungicides |
| 04/20/2000 | CA2346943A1 Cyclic tetrapeptide compound and use thereof |
| 04/20/2000 | CA2346775A1 Protein kinase homologs |
| 04/20/2000 | CA2345132A1 Oral combination of lufenuron and nitenpyram against fleas |
| 04/19/2000 | CN1251130A Isolated viable parasate intestinal cells |